Primary Site >> Colorectal Cancer

Gene >> BTK

Journal: Ann Surg Oncol. 2000 Oct;7(9):692-5.
Title: Analysis of the genetic alterations in a case of juvenile multiple colon carcinoma with hypogammaglobulinemia.
Author: Mimori, K|Mori, M|Adachi, Y|Antonyak, M A|Kinoshita, M|Kusaka, H|Sugimachi, K
PMID: 11034248
Journal: Neth J Med. 2002 Apr;60(3):140-7.
Title: Hypogammaglobulinaemia: cumulative experience in 49 patients in a tertiary care institution.
Author: Van der Hilst, J C H|Smits, B W|van der Meer, J W M
PMID: 12164371
Journal: Clin Gastroenterol Hepatol. 2008 Jan;6(1):115-9.
Title: Multiple colorectal neoplasms in X-linked agammaglobulinemia.
Author: Brosens, Lodewijk A A|Tytgat, Kristien M A J|Morsink, Folkert H M|Sinke, Richard J|Ten Berge, Ineke J M|Giardiello, Francis M|Offerhaus, G Johan A|Keller, Josbert J
PMID: 17967562
Journal: Sci Signal. 2009 May 26;2(72):ra25.
Title: Bruton's tyrosine kinase revealed as a negative regulator of Wnt-beta-catenin signaling.
Author: James, Richard G|Biechele, Travis L|Conrad, William H|Camp, Nathan D|Fass, Daniel M|Major, Michael B|Sommer, Karen|Yi, XianHua|Roberts, Brian S|Cleary, Michele A|Arthur, William T|MacCoss, Michael|Rawlings, David J|Haggarty, Stephen J|Moon, Randall T
PMID: 19471023
Journal: Proc Natl Acad Sci U S A. 2015 Mar 3;112(9):E966-72.
Title: Therapeutic antitumor immunity by checkpoint blockade is enhanced by ibrutinib, an inhibitor of both BTK and ITK.
Author: Sagiv-Barfi, Idit|Kohrt, Holbrook E K|Czerwinski, Debra K|Ng, Patrick P|Chang, Betty Y|Levy, Ronald
PMID: 25730880
Journal: Oncogene. 2016 Aug 18;35(33):4368-78.
Title: A novel oncogenic BTK isoform is overexpressed in colon cancers and required for RAS-mediated transformation.
Author: Grassilli, E|Pisano, F|Cialdella, A|Bonomo, S|Missaglia, C|Cerrito, M G|Masiero, L|Ianzano, L|Giordano, F|Cicirelli, V|Narloch, R|D'Amato, F|Noli, B|Ferri, G L|Leone, B E|Stanta, G|Bonin, S|Helin, K|Giovannoni, R|Lavitrano, M
PMID: 26804170
Journal: Apoptosis. 2017 Nov;22(11):1344-1352.
Title: The Btk-dependent PIP5K1gamma lipid kinase activation by Fas counteracts FasL-induced cell death.
Author: Rossin, Aurelie|Lounnas, Nadia|Durivault, Jerome|Miloro, Giorgia|Gagnoux-Palacios, Laurent|Hueber, Anne-Odile
PMID: 28879546
Journal: Br J Pharmacol. 2018 Mar;175(5):743-762.
Title: Simultaneous use of erythropoietin and LFM-A13 as a new therapeutic approach for colorectal cancer.
Author: Tankiewicz-Kwedlo, Anna|Hermanowicz, Justyna Magdalena|Domaniewski, Tomasz|Pawlak, Krystyna|Rusak, Malgorzata|Pryczynicz, Anna|Surazynski, Arkadiusz|Kaminski, Tomasz|Kazberuk, Adam|Pawlak, Dariusz
PMID: 29160911
Journal: Int J Mol Sci. 2018 Apr 23;19(4). pii: ijms19041262.
Title: Erythropoietin Intensifies the Proapoptotic Activity of LFM-A13 in Cells and in a Mouse Model of Colorectal Cancer.
Author: Tankiewicz-Kwedlo, Anna|Hermanowicz, Justyna Magdalena|Pawlak, Krystyna|Czarnomysy, Robert|Bielawski, Krzysztof|Prokop, Izabela|Pawlak, Dariusz
PMID: 29690619